DuPont Completes Acquisition of Donatelle Plastics Incorporated

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WILMINGTON, Del., July 29, 2024 /PRNewswire/ — DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Donatelle Plastics (“Donatelle”), a leading medical device company specializing in medical components and devices.

“I’m pleased to welcome the talented Donatelle colleagues to DuPont,” said Jon Kemp, President, DuPont Electronics & Industrial (E&I). “We’re excited to add Donatelle’s best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I’s healthcare offerings.”

With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle has a strong growth profile with offerings aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.  

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-completes-acquisition-of-donatelle-plastics-incorporated-302208211.html

SOURCE DuPont

Staff

Recent Posts

cbdMD Expands Oasis Social Tonics to Total Wine

Charlotte, North Carolina--(Newsfile Corp. - June 24, 2025) - cbdMD, Inc. (NYSE American: YCBD), a…

11 minutes ago

MedsEngine Helps Medical Practices Unlock $30,000 Per Provider in Additional Annual Revenue

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a leader in chronic disease management software, announced today that medical practices…

1 hour ago

Trially AI Taps Serial Entrepreneur Christian Smith as CRO to Expand AI Clinical Trial Enrollment Across U.S.

KANSAS CITY, Mo.--(BUSINESS WIRE)--#AIinHealthcare--Trially®, a breakthrough AI clinical trial recruitment technology to unlock faster qualified…

1 hour ago

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer

GRAND RAPIDS, Mich., June 24, 2025 /PRNewswire/ -- cultivate(MD), a leading medical device venture capital company, is…

1 hour ago

Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through Clinically Validated AI Imaging Solution

OXFORD, England and CHICAGO, Ill., June 24, 2025 /PRNewswire/ -- Today, Brainomix, a pioneer in…

1 hour ago

Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius(TM) with Apple Vision Pro at Rush University Medical Center

Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that…

5 hours ago